SSCP (Summary of Safety and Clinical Performance): Article 32, Which Devices, Content, Updates and EUDAMED

SUMMARY
The SSCP (Summary of Safety and Clinical Performance) is the summary of safety and clinical performance under Article 32 of the Tıbbi Cihaz Yönetmeliği (Medical Device Regulation). It is prepared by the manufacturer for implantable devices and class III devices, validated by the notified body and made publicly available through EUDAMED.
In this article we give the full text of the Article, the update obligation, the link with the instructions for use and EUDAMED, the counterpart for IVD devices and the ÜTS side, with word-for-word quotations from the regulation text.
For the ÜTS registration of your class III and implantable devices: Medical Device ÜTS Registration Consultancy
Contents
1. For Which Devices Is the SSCP Prepared?
Paragraph one of Article 32 of the Tıbbi Cihaz Yönetmeliği:
“ARTICLE 32 - (1) The summary of safety and clinical performance;”
“(a) Excluding custom-made devices and devices intended for investigation, it is prepared by the manufacturer for implantable devices and class III devices.”
The point treats two groups separately: implantable devices and class III devices. The manufacturer prepares it; custom-made devices and devices intended for investigation are outside the scope. For class III devices, see our article on class III medical devices.
2. Who Writes It and Who Validates It
“(b) It is written in a manner clear to the intended user and, where relevant, to the patient, and is made publicly available through EUDAMED.”
“(c) The draft summary forms part of the documentation to be submitted to the notified body involved in the conformity assessment under Article 52 and is validated by that body. After validating the summary, the notified body uploads it to EUDAMED. The manufacturer states on the label or in the instructions for use where the summary is available.”
Prepares it: the manufacturer (32/1-a).
Validates it and uploads it to EUDAMED: the notified body involved in the conformity assessment (32/1-c).
States where the summary is available on the label or in the instructions for use: the manufacturer (32/1-c).
3. Minimum Content of the SSCP
Paragraph two of Article 32:
“(2) The summary of safety and clinical performance shall include, as a minimum, the following:”
“(a) Information identifying the device and the manufacturer, including the Basic UDI-DI and, if already issued, the single registration number.”
“(b) The intended purpose of the device, indications, contraindications and target populations.”
“(c) A description of the device, including a reference to previous generation(s) or variants if such exist, and a description of the differences, as well as, where relevant, a description of the accessories, other devices and products which are intended to be used in combination with the device.”
“(ç) Possible diagnostic or therapeutic alternatives.”
“(d) Reference to any harmonized standards and common specifications applied.”
“(e) The summary of the clinical evaluation as referred to in Annex XIV and relevant information on post-market clinical follow-up.”
“(f) Suggested profile and training for users.”
“(g) Residual risks and undesirable effects, warnings and precautions.”
For the Basic UDI-DI in point (a), see our article What is the Basic UDI-DI, and for the standards in point (d), see our articles on harmonized standards and common specifications.
4. How Often Is the SSCP Updated?
Paragraph ten of Article 61:
“(10) The clinical evaluation and its documentation shall be updated throughout the life cycle of the device concerned with clinical data obtained from the implementation of the manufacturer's post-market clinical follow-up plan in accordance with Part B of Annex XIV and the post-market surveillance plan referred to in Article 82. For class III devices and implantable devices, the post-market clinical follow-up evaluation report and, where applicable, the summary of safety and clinical performance referred to in Article 32 shall be updated with such data at least once a year.”
Under the third paragraph of Article 81, post-market surveillance data is also used to update this summary:
“(ç) Updating the summary of safety and clinical performance referred to in Article 32,”
Under point 4.10 of Annex VII, the notified body ensures that the latest updated version of the clinical evaluation is reflected appropriately in the instructions for use and, where applicable, in the summary of safety and performance. For the clinical evaluation and PMCF, see our article on clinical evaluation and PMCF, and for post-market surveillance, see our article on post-market surveillance and PSUR.
5. The SSCP Link in the Instructions for Use
Under point 23.4 of Annex I, one of the items of information to be contained in the instructions for use is:
“(ç) Where applicable, links to the summary of safety and clinical performance referred to in Article 32,”
For the other content of the instructions for use, see our article on Turkish label and instructions for use. For the information to be given to patients with implantable devices, see our article on implant card.
6. The SSCP in EUDAMED: Registration Information and Transition
Under Part A of Annex VI, one of the items of information to be submitted in the registration of the device is:
“2.14. In the case of class III or implantable devices, the summary of safety and clinical performance,”
Under Article 57, the electronic system on notified bodies and on certificates also contains this summary:
“(ğ) The summary of safety and clinical performance referred to in Article 32.”
The point at which the upload obligation begins during the transitional period is set out in the seventeenth paragraph of Provisional Article 1:
“(c) By way of derogation from point (a) of the first paragraph of Article 111, where a certificate is entered into Eudamed in accordance with point (b) of this paragraph, the obligations to upload the summary of safety and clinical performance under the first paragraph of Article 32 and to inform the competent authorities under the first paragraph of Article 55, through the electronic system referred to in point (ç) of the second paragraph of Article 33, apply to the devices referred to in point (a).”
The EUDAMED Questions and Answers text published in Turkish by the TİTCK:
“The NB's obligation to upload the SS(C)P under MDR Article 32(1) and IVDR Article 29(1) applies from the moment the relevant certificate is registered in Eudamed.”
“The NB/CRF module has been open for voluntary use since October 2021. NBs can already register certificates and SS(C)Ps in Eudamed.”
For the EUDAMED modules, see our article on EUDAMED device registration.
7. For IVD Devices: Summary of Safety and Performance
Article 30 of the İn Vitro Tanı Amaçlı Tıbbi Cihaz Yönetmeliği (In Vitro Diagnostic Medical Device Regulation) provides for a similar summary for IVD devices:
“ARTICLE 30 - (1) The summary of safety and performance:”
“(a) Excluding devices for performance studies, it is prepared by the manufacturer for class C and D devices,”
In place of the summary of the clinical evaluation, the content of the IVD summary contains a summary of the performance evaluation and information on post-market performance follow-up; it also includes the following point:
“(e) Metrological traceability of assigned values.”
For the IVD classes, see our page on IVD device classification.
8. The Counterpart of the SSCP in ÜTS
The TİTCK ÜTS Registration Guide (TCKKD-KLVZ-03) has no separate document type or registration field for the SSCP. The summary appears in the guide in the definition of the Basic UDI-DI:
“(ggg) Basic UDI-DI: the identifier of the device assigned at the level of the unit of use, which is the main key in databases and in the relevant documentation (e.g. EU certificates, EU declaration of conformity, technical documentation and summary of safety and clinical performance) for linking devices with the same intended purpose, risk class and essential design and manufacturing characteristics,”
In ÜTS, the EU certificate and the EU declaration of conformity to which the device is linked are entered through document registration, and the device through product registration. For the steps, see our articles on ÜTS document registration and ÜTS medical device product registration.
9. Frequently Asked Questions
For which devices is the SSCP mandatory?
Under point (a) of the first paragraph of Article 32, it is prepared by the manufacturer for implantable devices and class III devices, excluding custom-made devices and devices intended for investigation.
Who uploads the SSCP to EUDAMED?
Under point (c), the notified body uploads the summary to EUDAMED after validating it. The manufacturer states where the summary is available on the label or in the instructions for use.
How often is the SSCP updated?
Under the tenth paragraph of Article 61, for class III and implantable devices, at least once a year, where applicable, with PMCF and post-market surveillance data.
Is there an SSCP for IVD devices?
Under Article 30 of the IVD Regulation, a summary of safety and performance is prepared by the manufacturer for class C and D devices, excluding devices for performance studies.
Is the SSCP uploaded to ÜTS?
The TCKKD-KLVZ-03 guide has no separate document type for the SSCP. Under Article 32, the summary is made publicly available through EUDAMED.
For the ÜTS registration of your class III and implantable devices: Medical Device ÜTS Registration Consultancy
Sources



